BR112015006058A2 - métodos para tratamento de hcv - Google Patents

métodos para tratamento de hcv

Info

Publication number
BR112015006058A2
BR112015006058A2 BR112015006058A BR112015006058A BR112015006058A2 BR 112015006058 A2 BR112015006058 A2 BR 112015006058A2 BR 112015006058 A BR112015006058 A BR 112015006058A BR 112015006058 A BR112015006058 A BR 112015006058A BR 112015006058 A2 BR112015006058 A2 BR 112015006058A2
Authority
BR
Brazil
Prior art keywords
treatment methods
hcv treatment
hcv
methods
inhibitors
Prior art date
Application number
BR112015006058A
Other languages
English (en)
Inventor
A Collins Christine
J Maring Clarence
A Degoey David
K Pratt John
Dachun Liu
C Mistry Neeta
Krishnan Preethi
Wagner Rolf
J Pilot-Matias Tami
M Kati Warren
Original Assignee
Abbvie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc filed Critical Abbvie Inc
Publication of BR112015006058A2 publication Critical patent/BR112015006058A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

resumo “métodos para tratamento de hcv” são descritos inibidores de hcv pangenotípicos. esta invenção também se refere a métodos de uso desses inibidores para tratar infecção por hcv.
BR112015006058A 2012-09-18 2013-09-17 métodos para tratamento de hcv BR112015006058A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261702569P 2012-09-18 2012-09-18
PCT/US2013/060122 WO2014047048A1 (en) 2012-09-18 2013-09-17 Methods for treating hepatitis c

Publications (1)

Publication Number Publication Date
BR112015006058A2 true BR112015006058A2 (pt) 2017-07-04

Family

ID=49304328

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015006058A BR112015006058A2 (pt) 2012-09-18 2013-09-17 métodos para tratamento de hcv

Country Status (14)

Country Link
US (1) US20140080886A1 (pt)
EP (1) EP2897609A1 (pt)
JP (1) JP2015528513A (pt)
CN (1) CN104780920A (pt)
AU (1) AU2013318311A1 (pt)
BR (1) BR112015006058A2 (pt)
CA (1) CA2885024A1 (pt)
HK (1) HK1209320A1 (pt)
MX (1) MX2015003500A (pt)
RU (1) RU2015114566A (pt)
SG (1) SG11201502108RA (pt)
TW (1) TW201412309A (pt)
WO (1) WO2014047048A1 (pt)
ZA (1) ZA201501758B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10201584B1 (en) * 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
US20150141351A1 (en) * 2013-11-18 2015-05-21 AbbVie Deutschland GmbH & Co. KG Solid Pharmaceutical Compositions
CN109689063A (zh) 2016-04-28 2019-04-26 埃默里大学 含有炔烃的核苷酸和核苷治疗组合物及其相关用途
CN113862231B (zh) * 2021-10-08 2024-02-13 中山大学 一种3a型丙肝病毒亚基因组复制子及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103819459B (zh) * 2009-06-11 2017-05-17 艾伯维巴哈马有限公司 抗病毒化合物
DE202012012954U1 (de) * 2011-10-21 2014-08-12 Abbvie Inc. Eine Kombination aus mindestens zwei direkt wirkenden antiviralen Wirkstoffen (DAAs) für die Verwendung zur Behandlung von HCV

Also Published As

Publication number Publication date
JP2015528513A (ja) 2015-09-28
EP2897609A1 (en) 2015-07-29
CN104780920A (zh) 2015-07-15
ZA201501758B (en) 2016-01-27
SG11201502108RA (en) 2015-05-28
WO2014047048A1 (en) 2014-03-27
US20140080886A1 (en) 2014-03-20
RU2015114566A (ru) 2016-11-10
MX2015003500A (es) 2015-06-22
CA2885024A1 (en) 2014-03-27
HK1209320A1 (en) 2016-04-01
AU2013318311A1 (en) 2015-04-02
TW201412309A (zh) 2014-04-01

Similar Documents

Publication Publication Date Title
BR112015006037A2 (pt) métodos para tratamento de hcv
CO2017006230A2 (es) Compuestos de n-((het)arilmetil)-heteroaril-carboxamidas como inhibidores de calicreína plasmática
EA201792205A1 (ru) Гетероциклические соединения как ингибиторы lsd1
PH12017500207A1 (en) Indoles for use in influenza virus infection
CR20140231A (es) Derivados de ácido benzotiazol-6-il acético y su uso para tratar una infección por vih
EA201691421A1 (ru) Гетероарилы и их применение
UY34851A (es) Inhibidores macrocíclicos de virus flaviviridae
EA201591509A1 (ru) Ингибиторы cdc7
UY34401A (es) Métodos para el tratamiento de hcv
CY1112077T1 (el) Θεραπεια με πιρφενιδονη αποφευγοντας την φλουβοξαμινη
UY34402A (es) Métodos para el tratamiento de hcv
EA201171367A1 (ru) Винилиндазолильные соединения
EA201790571A1 (ru) Пирролопиримидины для применения при инфекции, вызванной вирусом гриппа
EA201591786A1 (ru) Монотерапия gla для применения в лечении рака
EA201490944A1 (ru) Двойной ингибитор met и vegf для лечения рака
UA110813C2 (uk) Лікування ліподистрофії
EA201370071A1 (ru) Способы и композиции для лечения рака легких
MX2016005393A (es) Metodos para tratar vhc.
BR112015006056A2 (pt) métodos para tratar hcv
EA202091676A1 (ru) Способ лечения потери костной массы альвеолярного отростка посредством применения антител к склеростину
CY1120877T1 (el) Συνθεσεις και μεθοδοι για την αντιμετωπιση της κοιλιοκακης
EA201692358A1 (ru) Производные изоиндолина для применения в лечении вирусной инфекции
EA201201296A1 (ru) Способы лечения диабетических язв стопы
UA107346C2 (en) Use of nifuratel to treat infections caused by atopobium species
EA201690227A1 (ru) Азаиндольные соединения, их получение и способы их применения

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]